Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DOCCURA ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   7.1% 4.2% 6.0% 16.4% 11.6% 11.8% 18.3% 17.9%   Credit score (0-100)   35 49 39 10 20 19 8 8   Credit rating   BBB BBB BBB BB BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,398 1,820 1,507 1,479 1,092 972 0.0 0.0   EBITDA   91.6 436 78.1 191 36.5 248 0.0 0.0   EBIT   84.9 420 75.2 188 33.6 248 0.0 0.0   Pre-tax profit (PTP)   84.7 420.0 75.4 186.2 31.6 247.6 0.0 0.0   Net earnings   66.1 327.7 58.6 144.6 23.8 192.7 0.0 0.0   Pre-tax profit without non-rec. items   84.7 420 75.4 186 31.6 248 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   14.4 8.5 5.7 2.8 0.0 0.0 0.0 0.0   Shareholders equity total   1,097 1,155 887 133 157 350 310 310   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,616 1,726 1,666 508 490 660 310 310   Net Debt   -727 -667 -318 -210 -100 -101 -310 -310     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,398 1,820 1,507 1,479 1,092 972 0.0 0.0   Gross profit growth   -17.6% 30.2% -17.2% -1.9% -26.2% -10.9% -100.0% 0.0%   Employees   0 2 2 2 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% -50.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,616 1,726 1,666 508 490 660 310 310   Balance sheet change%   12.6% 6.8% -3.5% -69.5% -3.6% 34.8% -53.1% 0.0%   Added value   91.6 436.2 78.1 191.3 36.5 247.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -13 -22 -6 -6 -6 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   6.1% 23.1% 5.0% 12.7% 3.1% 25.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   5.6% 25.1% 4.4% 17.3% 6.8% 43.1% 0.0% 0.0%   ROI %   7.6% 37.3% 7.4% 37.0% 23.2% 97.8% 0.0% 0.0%   ROE %   5.9% 29.1% 5.7% 28.4% 16.4% 76.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   67.9% 66.9% 53.2% 26.2% 32.1% 53.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -793.1% -152.9% -407.5% -109.9% -274.5% -40.8% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   124.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   3.2 3.6 2.1 1.5 1.5 2.6 0.0 0.0   Current Ratio   3.2 3.6 2.1 1.5 1.5 2.6 0.0 0.0   Cash and cash equivalent   726.8 666.9 318.2 210.2 100.1 101.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   1,100.7 1,235.2 881.0 172.2 162.2 404.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 218 39 96 36 248 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 218 39 96 36 248 0 0   EBIT / employee   0 210 38 94 34 248 0 0   Net earnings / employee   0 164 29 72 24 193 0 0